Correlation between multi-parameter echocardiographic indicators and adverse pregnancy outcomes in women of advanced maternal age with pregnancy-induced hypertension syndrome: clinical application value

多参数超声心动图指标与高龄妊娠高血压综合征患者不良妊娠结局的相关性:临床应用价值

阅读:1

Abstract

INTRODUCTION: Hypertensive disorders of pregnancy are a major cause of maternal and perinatal morbidity and mortality, particularly among women of advanced maternal age. MATERIALS AND METHODS: This retrospective study evaluated the correlation between echocardiographic parameters and adverse pregnancy outcomes in 240 women aged ≥35 years diagnosed with pregnancy-induced hypertension syndrome (PIHS) from February 2019 to June 2022. Patients were classified into a favorable outcome group (n = 183) and an adverse outcome group (n = 57). Echocardiographic indicators-including ejection fraction (EF), stroke volume (SV), cardiac output (CO), E/A ratio, early diastolic mitral annular velocity (E'), E/E' ratio, left atrial volume index (LAVI), pulmonary venous flow velocities (S-, D-, Ar-waves), and myocardial performance (Tei) index-were compared between groups. RESULTS: Women with adverse outcomes had significantly lower EF, SV, CO, E/A ratio, and E', while showing higher E/E', LAVI, Ar-wave velocity, and Tei index, with reduced S- and D-wave velocities (all p < 0.001). A history of hypertension, nephritis, and a family history of hypertension were also identified as significant clinical risk factors. Multivariable logistic regression confirmed that both clinical and echocardiographic parameters were independently associated with poor outcomes. Receiver operating characteristic analysis demonstrated high discriminative power for key indices (AUC range: 0.78-0.90), and a combined model integrating multiple echocardiographic variables achieved an AUC of 0.925, indicating excellent predictive performance. DISCUSSION: These findings suggest that multi-parameter echocardiographic assessment provides a reliable, non-invasive approach for identification of high-risk PIHS patients, supporting more effective monitoring and timely intervention to improve maternal and fetal prognosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。